Simulations Plus

Simulations Plus Total Assets

The Total Assets of Simulations Plus (SLP) as of Oct 8, 2026 is 131.94 M USD. In the previous year, Total Assets was 207.64 M USD — a change of -36.46% (lower).

Total Assets

131.94 MUSD

YoY

-36.46%

Last updated:

Total Assets of Simulations Plus is 2025 131.94 M USD. Total Assets of Simulations Plus was 2024 207.64 M USD. It decreases by -36.46% lower compared to the previous year.

The Simulations Plus Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
44.15 M USD
Jan 1, 2019
46.09 M USD
Jan 1, 2020
169.82 M USD
Jan 1, 2021
181.61 M USD
Jan 1, 2022
190.50 M USD
Jan 1, 2023
192.64 M USD
Jan 1, 2024
207.64 M USD
Jan 1, 2025
131.94 M USD
The Simulations Plus Total Assets history
YEARTotal AssetsYoY
131.94 MUSD-36.46%
207.64 MUSD+7.78%
192.64 MUSD+1.12%
190.50 MUSD+4.89%
181.61 MUSD+6.95%
169.82 MUSD+268.41%
46.09 MUSD+4.41%
44.15 MUSD+14.64%
38.51 MUSD+38.46%
27.81 MUSD+1.72%
27.34 MUSD+30.33%
20.98 MUSD—
Access this data via the Eulerpool API

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Total Assets of Simulations Plus is 131.94 M USD in 2025.

Total Assets of Simulations Plus changed from 207.64 M USD to 131.94 M USD, representing a -36.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Simulations Plus

All Key Metrics — Simulations Plus